OC
MDSO

Oppenheimer & Close’s Medidata Solutions, Inc. MDSO Stock Holding History

Oppenheimer & Close’s Portfolio MDSO Stock Details MDSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,530
Closed -$275K – 36
2017
Q3 		$275K Hold
3,530
– – 0.28% 32
2017
Q2 		$276K Sell
3,530
-120
-3% -$8.36K 0.28% 33
2017
Q1 		$210K Buy
+3,650
New +$197K 0.19% 36
2015
Q3 		– Sell
-3,760
Closed -$204K – 53
2015
Q2 		$204K Buy
+3,760
New +$202K 0.17% 49
2014
Q2 		– Sell
-3,860
Closed -$210K – 54
2014
Q1 		$210K Sell
3,860
-80
-2% -$4.87K 0.18% 48
2013
Q4 		$238K Sell
3,940
-2,060
-34% -$114K 0.21% 47
2013
Q3 		$297K Buy
+6,000
New +$265K 0.21% 55

Other funds holding MDSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

Oppenheimer & Close's MDSO Position: Q4 2017 in Review

Oppenheimer & Close sold out of Medidata Solutions, Inc. (MDSO) in Q4 2017, closing a stake of 3,530 shares — an estimated $275K sold.

Oppenheimer & Close first reported a position in MDSO in Q3 2013 and held it in 7 quarters. The position peaked at $297K in Q3 2013. 285 funds tracked by Wall St. Rank hold MDSO as of Q4 2017.

  • Oppenheimer & Close reported no remaining Medidata Solutions, Inc. position as of Q4 2017 after selling out during the quarter.
  • Oppenheimer & Close sold 3,530 Medidata Solutions, Inc. shares in Q4 2017, an estimated $275K.
  • Oppenheimer & Close first reported a position in Medidata Solutions, Inc. in Q3 2013 and held it in 7 quarters.
  • Oppenheimer & Close's Medidata Solutions, Inc. position peaked at $297K in Q3 2013.
  • 285 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2017.

Based on Oppenheimer & Close's 13F filing for Q4 2017, filed 13 Feb 2018.